BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 118655)

  • 1. New vistas on the role of platelets in bronchoconstrictions.
    Chignard M; Lefort J; Vargaftig BB
    Agents Actions Suppl; 1979; (6):105-11. PubMed ID: 118655
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential effects of prostacyclin and prostaglandin E1 on bronchoconstriction and thrombocytopenia during collagen and arachidonate infusions and anaphylactic shock in the guinea-pig.
    Vargaftig BB; Lefort J
    Prostaglandins; 1979 Oct; 18(4):519-28. PubMed ID: 394199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the metabolites of arachidonate in platelet-dependent and independent experimental bronchoconstriction.
    Vargaftig BB; Lefort J; Wal F; Chignard M
    Bull Eur Physiopathol Respir; 1981; 17(4):723-36. PubMed ID: 7034826
    [No Abstract]   [Full Text] [Related]  

  • 4. Bronchoactive metabolites of arachidonic acid and their role in airway function.
    Spannhake EW; Hyman AL; Kadowitz PJ
    Prostaglandins; 1981 Dec; 22(6):1013-26. PubMed ID: 6801729
    [No Abstract]   [Full Text] [Related]  

  • 5. Some properties of mouse platelets.
    Rosenblum WI; Nelson GH; Cockrell CS; Ellis EF
    Thromb Res; 1983 May; 30(4):347-55. PubMed ID: 6412387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of PGI2 on platelet aggregation induced by various stimulants.
    Ohtsu A; Hoshina K; Kurozumi S; Hashimoto Y; Noguchi T; Nicolaou KC
    Nihon Ketsueki Gakkai Zasshi; 1979 Aug; 42(4):659-66. PubMed ID: 388963
    [No Abstract]   [Full Text] [Related]  

  • 7. Regulatory role of cyclic adenosine 3',5'-monophosphate on the platelet cyclooxygenase and platelet function.
    Fitzpatrick FA; Gorman RR
    Biochim Biophys Acta; 1979 Jan; 582(1):44-58. PubMed ID: 216415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Some biochemical activities of 10,10-difluoro-13-dehydroprostacyclin, a chemically stable analog of prostacyclin, in human blood platelets.
    Harris DN; Phillips MB; Michel IM; Goldenberg HJ; Haslanger MF; Antonaccio MJ; Fried J
    Thromb Res; 1981 Aug 15-Sep 1; 23(4-5):387-99. PubMed ID: 6275567
    [No Abstract]   [Full Text] [Related]  

  • 9. Intrathoracic platelet accumulation in the guinea-pig induced by intravenous administration of arachidonic acid--effect of cyclooxygenase and thromboxane synthetase inhibitors.
    Barrett PA; Butler KD; Shand RA; Wallis RB
    Thromb Haemost; 1986 Dec; 56(3):311-7. PubMed ID: 3105107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antagonism of prostaglandins I2, E1 and D2 by prostaglandin E2 in human platelets.
    Bonne C; Martin B; Watada M; Regnault F
    Thromb Res; 1981 Jan 1-15; 21(1-2):13-22. PubMed ID: 6262942
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of lipids in platelet function: with particular reference to the arachidonic acid pathway.
    Marcus AJ
    J Lipid Res; 1978 Sep; 19(7):793-826. PubMed ID: 101634
    [No Abstract]   [Full Text] [Related]  

  • 12. Prostaglandins E1 and E2, but neither prostacyclin nor prostaglandin D2 have anti-aggregating activity in chicken blood.
    Bult H; Wechsung E; Houvenaghel A; Herman AG
    Arch Int Pharmacodyn Ther; 1981 Feb; 249(2):306-8. PubMed ID: 7013724
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclic adenosine 3',5'-monophosphate inhibits the availability of arachidonate to prostaglandin synthetase in human platelet suspensions.
    Minkes M; Stanford N; Chi MM; Roth GJ; Raz A; Needleman P; Majerus PW
    J Clin Invest; 1977 Mar; 59(3):449-54. PubMed ID: 190267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet-lung in vivo interactions: an artifact of a multi-purpose model?
    Vargaftig BB; Lefort J; Prancan AV; Chignard M; Benveniste J
    Haemostasis; 1979; 8(3-5):171-82. PubMed ID: 511008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelets and prostaglandins.
    Holmsen H
    Cephalalgia; 1986; 6 Suppl 4():33-42. PubMed ID: 3098432
    [No Abstract]   [Full Text] [Related]  

  • 16. A metabolite of sulphinpyrazone that is largely responsible for the effect of the drug on the platelet prostaglandin pathway.
    Pay GF; Wallis RB; Zelaschi D
    Biochem Soc Trans; 1980 Dec; 8(6):727-8. PubMed ID: 7461266
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of agents that alter cyclic AMP on arachidonate-induced platelet aggregation in the dog.
    Johnson GJ; Rao GH; Leis LA; White JG
    Blood; 1980 May; 55(5):722-9. PubMed ID: 6244866
    [No Abstract]   [Full Text] [Related]  

  • 18. [Role of prostaglandins, thromboxanes and prostacyclin in regulating the thrombocyte aggregation process and liberation reaction normally and in pathology].
    Baluda VP; Sushkevich GN; Lukoianova TI
    Patol Fiziol Eksp Ter; 1980; (4):80-5. PubMed ID: 6251418
    [No Abstract]   [Full Text] [Related]  

  • 19. Prostaglandin E2 potentiation of platelet aggregation induced by LASS endoperoxide: absent in storage pool disease, normal after aspirin ingestion.
    Weiss HJ; Willis AL; Kuhn D; Brand H
    Br J Haematol; 1976 Feb; 32(2):257-72. PubMed ID: 1247498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic AMP inhibits synthesis of prostaglandin endoperoxide (PGG2) in human platelets.
    Malmsten C; Granström E; Samuelsson B
    Biochem Biophys Res Commun; 1976 Jan; 68(2):569-76. PubMed ID: 175797
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.